For immediate release 5 July 2010
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Allotment of scrip shares to Chairman and Investment Adviser
David Staples (the Company's Chairman) and MedicX Adviser Ltd (the Company's Investment Adviser) elected to participate in the Company's scrip dividend scheme and were allotted 547 and 10,953 new ordinary shares of no par value in the Company (the "Shares") respectively. The Shares were admitted for trading on the Main Market of the London Stock Exchange on 30 June 2010 and rank pari passu with the Company's existing ordinary shares.
A copy of the document relating to the Scrip Dividend Alternative dated 17 May 2010 is available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:
Financial Services Authority
25 The North Colonnade
Canary Wharf
London
E14 5HS
End
For further information please contact:
MedicX Group +44 (0)1483 869 500
Keith Maddin, Chairman
Mike Adams, Managing Director
Mark Osmond, Chief Financial Officer
Collins Stewart Europe Limited +44 (0)20 7523 8000
Andrew Zychowski/Lucy Lewis
Buchanan Communications +44(0)20 7466 5000
Charles Ryland/George Prassas
MedicX Fund Limited +44 (0)1481 723 450
David Staples, Chairman
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 55 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK.
The Company's website address is www.medicxfund.com.